eHealth, Inc. (EHTH) stock
EHTHNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31
$0.44−0.02 (-3.64%)
Close on Nov 12, 2026Market cap $14.09MP/E –Yield –
eHealth EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
eHealth's EPS for the twelve months ending Sep 30, 2026 was -$0.94, down 954.5% year over year. For fiscal 2025 it was -$0.34. The highest annual figure on record is $2.73 in fiscal 2019.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.34 | – |
| FY2024 | Dec 31, 2024 | -$1.19 | – |
| FY2023 | Dec 31, 2023 | -$2.37 | – |
| FY2022 | Dec 31, 2022 | -$4.36 | – |
| FY2021 | Dec 31, 2021 | -$4.59 | -373.2% |
| FY2020 | Dec 31, 2020 | $1.68 | -38.5% |
| FY2019 | Dec 31, 2019 | $2.73 | +27200.0% |
| FY2018 | Dec 31, 2018 | $0.01 | -99.2% |
| FY2017 | Dec 31, 2017 | $1.33 | +6550.0% |
| FY2016 | Dec 31, 2016 | $0.02 | – |
| FY2015 | Dec 31, 2015 | -$0.26 | – |
| FY2014 | Dec 31, 2014 | -$0.88 | -1077.8% |
| FY2013 | Dec 31, 2013 | $0.09 | -73.5% |
| FY2012 | Dec 31, 2012 | $0.34 | +9.7% |
| FY2011 | Dec 31, 2011 | $0.31 | -57.5% |
| FY2010 | Dec 31, 2010 | $0.73 | +19.7% |
| FY2009 | Dec 31, 2009 | $0.61 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.57 | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.18 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.58 | – |
| Q4 FY2025 | Dec 31, 2025 | $2.39 | -17.0% |
| Q3 FY2025 | Sep 30, 2025 | -$1.46 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.98 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.33 | – |
| Q4 FY2024 | Dec 31, 2024 | $2.88 | +97.3% |
| Q3 FY2024 | Sep 30, 2024 | -$1.83 | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.33 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.96 | – |
| Q4 FY2023 | Dec 31, 2023 | $1.46 | +217.4% |
| Q3 FY2023 | Sep 30, 2023 | -$1.68 | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.18 | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.01 | – |
| Q4 FY2022 | Dec 31, 2022 | $0.46 | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.72 | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.65 | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.46 | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.45 | -174.0% |
| Q3 FY2021 | Sep 30, 2021 | -$2.24 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.86 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.03 | -123.1% |
| Q4 FY2020 | Dec 31, 2020 | $1.96 | -45.3% |
| Q3 FY2020 | Sep 30, 2020 | -$0.55 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.13 | – |
| Q1 FY2020 | Mar 31, 2020 | $0.13 | – |
| Q4 FY2019 | Dec 31, 2019 | $3.58 | +186.4% |
| Q3 FY2019 | Sep 30, 2019 | -$0.47 | – |
| Q2 FY2019 | Jun 30, 2019 | -$0.25 | – |
| Q1 FY2019 | Mar 31, 2019 | -$0.24 | – |
| Q4 FY2018 | Dec 31, 2018 | $1.25 | -15.0% |
| Q3 FY2018 | Sep 30, 2018 | -$0.47 | – |
| Q2 FY2018 | Jun 30, 2018 | -$0.63 | – |
| Q1 FY2018 | Mar 31, 2018 | -$0.26 | -533.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.47 | – |
| Q3 FY2017 | Sep 30, 2017 | -$0.12 | – |
| Q2 FY2017 | Jun 30, 2017 | -$0.08 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.06 | – |
| Q4 FY2016 | Dec 31, 2016 | -$0.91 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?